New variations of human CC-chemokine receptors CCR3 and CCR4

Genes and Immunity

Volumn 1, Issue 2, 1999, Pages 97-104

  Kato, H ^a   Tsuchiya, N ^a   Izumi, S ^a   Miyamasu, M ^a   Nakajima, T ^a   Kawasaki, H ^b   Hirai, K ^a   Tokunaga, K ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Beh et disease; CCR3; CCR4; Eotaxin; SNP

Indexed keywords

CC CHEMOKINE RECEPTOR 3; CC CHEMOKINE RECEPTOR 4; CHEMOKINE RECEPTOR; MESSENGER RNA; PRIMER DNA;

ALLELE; ARTICLE; BIOSYNTHESIS; CHEMOTAXIS; FLOW CYTOMETRY; GENETIC SCREENING; GENETIC VARIABILITY; GENETICS; HUMAN; METABOLISM; MOLECULAR GENETICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATIC DISEASE;

ALLELES; CHEMOTAXIS; DNA PRIMERS; FLOW CYTOMETRY; GENETIC SCREENING; HUMANS; MOLECULAR SEQUENCE DATA; RECEPTORS, CHEMOKINE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHEUMATIC DISEASES; RNA, MESSENGER; VARIATION (GENETICS);

EID: 0033224335     PISSN: 14664879     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gene.6363638     Document Type: Article

References (48)

1. Baggiolini M, Dewald B, Moser B. Human chemokines: an update. Annu Rev Immunol 1997; 15: 675-705.
2. Baggiolini M. Chemokines and leukocyte traffic. Nature 1998; 392: 565-568.
3. Combadiere C, Ahuja SK, Murphy PM. Cloning and functional expression of a human eosinophil CC chemokine receptor. J Biol Chem 1995; 270: 16491-16494.
4. Ponath PD, Qin S, Post TW et al. Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. J Exp Med 1996; 183: 2437-2448.
5. Yamada H, Hirai K, Miyamasu M et al. Eotaxin is a potent chemotaxin for human basophils. Biochem Biophys Res Commun 1997; 231: 365-368.
6. Loetscher P, Uguccioni M, Bordoli L et al. CCR5 is characteristic of Th1 lymphocytes. Nature 1998; 391: 344-345.
7. Bonecchi R, Bianchi G, Bordignon PP et al. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 1998; 187: 129-133.
8. Sallusto F, Lenig D, Mackay CR, Lanzavecchia A. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med 1998; 187: 875-883.
9. Ward SG, Bacon K, Westwick J. Chemokines and T lymphocytes: more than attraction. Immunity 1998; 9: 1-11.
10. Sallusto F, Mackay CR, Lanzavecchia A. Selective expression of the eotaxin receptor CCR3 by human T helper cells. Science 1997; 277: 2005-2007.
11. Imai T, Baba M, Nishimura M et al. The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4. J Biol Chem 1997; 272: 15036-15042.
12. Imai T, Chantry D, Raport CJ et al. Macrophage-derived chemokine is a functional ligand for the CC chemokine receptor 4. J Biol Chem 1998; 273: 1764-1768.
13. Imai T, Yoshida T, Baba M et al. Molecular cloning of a novel T cell-directed CC chemokine expressed in thymus by signal sequence trap using Epstein-Barr virus vector. J Biol Chem 1996; 271: 21514-21521.
14. Chang M, McNinch J, Elias C III et al. Molecular cloning and functional characterization of a novel CC chemokine, stimulated T cell chemotactic protein (STCP-1) that specifically acts on activated T lymphocytes. J Biol Chem 1997; 272: 25229-25237.
15. Andrew DP, Chang M, McNinch J et al. STCP-1 (MDC) CC chemokine acts specifically on chronically activated Th2 lymphocytes and is produced by monocytes on stimulation with Th2 cytokines IL-4 and IL-13. J Immunol 1998; 161: 5027-5038.
16. Gerber BO, Zanni MP, Uguccioni M et al. Functional expression of the eotaxin receptor CCR3 in T lymphocytes co-localizing with eosinophils. Curr Biol 1997; 7: 836-843.
17. Rothenberg ME, MacLean JA, Pearlman E et al. Targeted disruption of the chemokine eotaxin partially reduces antigen-induced tissue eosinophilia. J Exp Med 1997; 185: 785-790.
18. Forssmann U, Uguccioni M, Loetscher P et al. Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes. J Exp Med 1997; 185: 2171-2176.
19. Choe H, Farzan M, Sun Y et al. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996; 85: 1135-1148.
20. Doranz BJ, Rucker J, Yi Y et al. A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR3, and CKR-2b as fusin cofactors. Cell 1996; 85: 1149-1158.
21. He J, Chen Y, Farzan M et al. CCR3 and CCR5 are co-receptors HIV-1 infection of microglia. Nature 1997; 385: 645-649.
22. Littman DR. Chemokine receptors: keys to AIDS pathogenesis? Cell 1998; 93: 677-680.
23. Cairns JS, D'Souza MP. Chemokines and HIV-1 second receptors: the therapeutic connection. Nature Med 1998; 4: 563-568.
24. Hadida F, Vieillard V, Autran B et al. HIV-specific T cell cytotoxicity mediated by RANTES via the chemokine receptor CCR3. J Exp Med 1998; 188: 609-614.
25. Pal R, Garzino-Demo A, Markham PD et al. Inhibition of HIV-1 infection by the β-chemokine MDC. Science 1997; 278:695-698.
26. Charlton B, Lafferty KJ. The Th1/Th2 balance in autoimmunity. Curr Opin Immunol 1995; 7: 793-798.
27. Kroemer G, Hirsch F, Gonzalez-Garcia A, Martinez C. Differential involvement of Th1 and Th2 cytokines in autoimmune diseases. Autoimmunity 1996; 24: 25-33.
28. Power CA, Meyer A, Nemeth K et al. Molecular cloning and functional expression of a novel CC chemokine receptor cDNA from a human basophilic cell line. J Biol Chem 1995; 270: 19495-19500.
29. Samson M, Soularue P, Vassart G, Parmentier M. The genes encoding the human CC-chemokine receptors CC-CKR1 to CC-CKR5 (CMKBR1-CMKBR5) are clustered in the p21.3-p24 region of chromosome 3. Genomics 1996; 36: 522-526.
30. Herz JM, Thomsen WJ, Yabrough GG. Molecular approaches to receptors as targets for drug discovery. J Recept Signal Transduction Res 1997; 17: 671-776.
31. Sheer A, Cotecchia S. Constitutively active G protein-coupled receptors: potential mechanisms of receptor activation. J Recept Signal Transduction Res 1997; 17: 57-73.
32. Raziuddin S, al-Dalaan A, Bahabri S et al. Divergent cytokine production profile in Behçet disease. Altered Th1/Th2 cell cytokine pattern. J Rheumatol 1998; 25: 329-333.
33. Rucker J, Samson M, Doranz BJ et al. Regions in β-chemokine receptors CCR5 and CCR2b that determine HIV-1 cofactor specificity. Cell 1996; 87: 437-446.
34. Samson M, LaRosa G, Libert F et al. The second extracellular loop of CCR5 is the major determinant of lignad specificity. J Biol Chem 1997; 40: 24934-24941.
35. Atchison RE, Gosling J, Monteclaro FS et al. Multiple extracellular elements of CCR5 and HIV-1 entry: dissociation from response to chemokines. Science 1996; 274: 1924-1926.
36. Arnett FC, Edworthy S, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-324.
37. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
38. International Study Group for Behçet's Disease. Criteria for diagnosis of Behçet's disease. Lancet 1990; 335: 1078-1080.
39. Tokunaga K, Imanishi T, Takahashi K, Juji T. On the origin and dispersal of East Asian populations as viewed from HLA haplotypes. In: Akazawa T, Szathmary EJ (eds). Prehistoric Mongoloid Dispersals. Oxford University Press: Oxford, 1996, pp 187-197.
40. Youn BS, Kim SH, Lyu MS et al. Molecular cloning and characterization of a cDNA, CHEMR1, encoding a chemokine receptor with a homology to the human C-C chemokine receptor, CCR-4. Blood 1997; 89: 4448-4460.
41. Bannai M, Tokunaga K, Lin L et al. Discrimination of human HLA-DRB1 alleles by PCR-SSCP (single-strand conformation polymorphism) method. Eur J Immunogenet 1994; 21: 1-9.
42. Hatta Y, Tsuchiya N, Matsushita M et al. Identification of the gene variations in human CD22. Immunogenetics 1999; 49: 280-286.
43. Sato K, Kawasaki H, Nagayama H et al. CC chemokine receptors, CCR-1 and CCR-3, are potentially involved in APC function of human peripheral blood monocyte-derived dendritic cells. Blood 1999; 93: 34-42.
44. Mawhorter SD, Stephany DA, Ottesen EA, Nutman TB. Identification of surface molecules associated with physiologic activation of eosinophils. Application of whole-blood flow cytometry to eosinophils. J Immunol 1996; 156: 4851-4858.
45. Miyamasu M, Hirai K, Takahashi Y et al. Chemotactic agonists induce cytokine generation in eosinophils. J Immunol 1995; 154: 1339-1349.
46. Miyamasu M, Misaki Y, Izumi S et al. Glucocorticoids inhibit chemokine generation by human eosinophils. J Allergy Clin Immunol 1998; 101: 75-83.
47. Taniguchi A, Kohsaka H, Carson DA. Competitive RT-PCR ELISA: a rapid sensitive and non-radioactive method to quantitate cytokine mRNA. J Immunol Methods 1994; 169: 101-109.
48. Zimmermann N, Bernstein JA, Rothenberg ME. Polymorphisms in the human CC chemokine receptor-3 gene. Biochim Biophys Acta 1998; 1442: 170-176.